Hormone Therapy

Dr Reddy's enters hormone replacement therapy segment with $32 mn buy

Dr Reddy's Laboratories has forayed into hormone replacement therapy segment by acquiring trademarks of specialty brands, Progynova and Cyclo-Progynova and related assets, for India from UK-headquartered Mercury Pharma Group for USD 32.15 million, according to a company statement. Progynova (estradiol valerate) is an oral hormone replacement therapy indicated for the treatment of estrogen deficiency symptoms and for the prevention of postmenopausal osteoporosis. Cyclo-Progynova (estradiol valerate and norgestrel) is a combined hormone replacement therapy indicated for the treatment of estrogen deficiency symptoms, providing both estrogen and progestogen components. As per IQVIA MAT December 2025, the brand recorded sales of Rs 100 crore. The acquisition strengthens Dr Reddy's gynaecology portfolio and marks a strategic entry into the hormone replacement therapy segment, the drug firm stated. "The acquisition will serve as the spearhead of our expansion into the HRT segment, ...

Science of happiness: How to activate your body's natural happy hormones

Serotonin, dopamine, oxytocin, endorphins are your natural happy hormones. Here's how simple lifestyle tweaks can lift your mood and lower stress, day after day

GSK India re-enters oncology segment with launch of Jemperli and Zejula

GSK India has launched Jemperli and Zejula for gynaecological cancers, marking its return to oncology a decade after divesting its portfolio to Novartis

Could your daily office chai be harming your hormones, making you sick?

Doctors warn that chai in polythene or substandard plastic cups may leach hormone-disrupting chemicals, raising cancer risk over time

Sanjay Bangar's son undergoes Hormone Replacement Therapy to become Anaya

Sanjay Bangar's son Aryan shared a post on Instagram showing his sex transformation journey to become a female, Anaya. Aryan underwent HRT to change gender

Indian pharmaceutical market registers over 8% growth in June 2024

GSK's antibiotic drug Augmentin and USV's anti-diabetic drug Glycomet GP continued to be the top-selling medicine brands with sales of Rs 76 crore and Rs 66 crore, respectively

Custom-blended hormone therapy may not be accurate, says study

This study showed that the dose of a compounded product received may be different from the actual prescribed dose

Hormone therapy safe for women with migraines: Study

Migraine headaches are common among women, but due to various health risks can be challenging to treat in the elderly